Variable | N (number) | % | |
---|---|---|---|
Menopausal | |||
Pre-menopausal | 111 | 58.73 | |
Post-menopausal | 78 | 41.27 | |
Grade | I | 13 | 6.8 |
II | 104 | 55 | |
III | 72 | 38.1 | |
Stage | I | 11 | 5.8 |
II | 127 | 67.2 | |
III | 51 | 27 | |
Tumor size | |||
T1 | 14 | 7.4 | |
T2 | 120 | 63.2 | |
T3 | 34 | 17.9 | |
T4 | 21 | 11.1 | |
ER status | |||
ER+ | 107 | 56.61 | |
ER− | 82 | 43.39 | |
PR status | |||
PR+ | 113 | 60 | |
PR− | 76 | 40 | |
Hormone-receptor status | |||
ER + PR+ | 103 | 54.5 | |
ER + PR− | 4 | 2.1 | |
ER − PR+ | 10 | 5.3 | |
ER − PR− | 72 | 38.1 |